Health Sciences Gr Stock Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Health Sciences are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Health Sciences Gr has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Health Sciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Health |
Health Sciences Relative Risk vs. Return Landscape
If you would invest 0.00 in Health Sciences Gr on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Health Sciences Gr or generate 0.0% return on investment over 90 days. Health Sciences Gr is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Health, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Health Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Sciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Health Sciences Gr, and traders can use it to determine the average amount a Health Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HESG |
Based on monthly moving average Health Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Health Sciences by adding Health Sciences to a well-diversified portfolio.
Health Sciences Fundamentals Growth
Health Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Health Sciences, and Health Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Pink Sheet performance.
| Return On Asset | -0.73 | |||
| Operating Margin | (73.91) % | |||
| Current Valuation | 39.41 K | |||
| Price To Sales | 0 X | |||
| Revenue | 358.43 K | |||
| EBITDA | (4.51 M) | |||
| Cash And Equivalents | 1.71 K | |||
| Total Debt | 407 K | |||
| Book Value Per Share | (0.11) X | |||
| Cash Flow From Operations | 38.99 K | |||
| Earnings Per Share | (0.13) X | |||
| Total Asset | 1.03 M | |||
| Retained Earnings | (32.46 M) | |||
| Current Asset | 67 K | |||
| Current Liabilities | 5.11 M | |||
About Health Sciences Performance
By analyzing Health Sciences' fundamental ratios, stakeholders can gain valuable insights into Health Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Health Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Health Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. Health Sciences is traded on OTC Exchange in the United States.Things to note about Health Sciences Gr performance evaluation
Checking the ongoing alerts about Health Sciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Health Sciences Gr help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health Sciences Gr generated a negative expected return over the last 90 days | |
| Health Sciences Gr has some characteristics of a very speculative penny stock | |
| Health Sciences Gr has high likelihood to experience some financial distress in the next 2 years | |
| Health Sciences Gr currently holds 407 K in liabilities. Health Sciences Gr has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Health Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Health Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Health Sciences Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Health to invest in growth at high rates of return. When we think about Health Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 358.43 K. Net Loss for the year was (54.49 K) with profit before overhead, payroll, taxes, and interest of 22.91 K. |
- Analyzing Health Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Health Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Health Sciences' pink sheet. These opinions can provide insight into Health Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Health Pink Sheet analysis
When running Health Sciences' price analysis, check to measure Health Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Sciences is operating at the current time. Most of Health Sciences' value examination focuses on studying past and present price action to predict the probability of Health Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Sciences' price. Additionally, you may evaluate how the addition of Health Sciences to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |